Erratum: Addendum: Technical standards and guidelines for spinal muscular atrophy testing (Genetics in Medicine (2011) 13(7) (686–694), (S1098360021046062), (10.1097/GIM.0b013e318220d523));Technical standards and guidelines for spinal muscular atrophy testing

Genetics in Medicine

Volumn 13, Issue 7, 2011, Pages 686-694

  Prior, Thomas W ^a   Nagan, Narasimhan ^b   Sugarman, Elaine A ^b   Batish, Sat Dev ^c   Braastad, Corey ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b Genzyme Genetics   (United States)

^c ATHENA DIAGNOSTICS INC   (United States)

Author keywords

carrier testing; genetic testing; genotype; phenotype; SMN1; SMN2; spinal muscular atrophy; survival motor neuron

Indexed keywords

GENE PRODUCT; SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2;

ALLELE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 5Q; CLINICAL LABORATORY; DNA SEQUENCE; ETHNICITY; GENE DOSAGE; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; LABORATORY TEST; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICAL RECORD; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; PATENT; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRENATAL SCREENING; PROFESSIONAL STANDARD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; SPINAL MUSCULAR ATROPHY;

EID: 79960834390     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/s41436-020-00961-6     Document Type: Erratum

References (46)

1. Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978;15:409-413. (Pubitemid 9093440)
2. Munstat TL, Davies KE. International SMA consortium meeting. Neuromuscular Disord 1992;2:423-428.
3. Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 1995;52:518-523.
4. Meldrum C, Scott C, Swoboda KJ. Spinal muscular atrophy genetic counseling access and genetic knowledge: parents perspective. J Child Neurol 2007;22:1019-1026. (Pubitemid 47308317)
5. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-165.
6. Burglen L, Lefebvre S, Clermont O, et al. Structure and organization of the human survival motor neuron (SMN) gene. Genomics 1996;32:479-482. (Pubitemid 26094355)
7. Monani UR, McPherson JD, Burghes AH. Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 2007;1445:330-336.
8. Echaniz-Laguna A, Miniou P, Bartholdi D, Melki J. The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet 1999;64:1354-1370.
9. Lefebvre S, Burlet P, Liu Q, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997;16:265-269. (Pubitemid 27280210)
10. Coovert DD, Le TT, McAndrew PE, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997;6:1205-1214. (Pubitemid 27351059)
11. Paushkin S, Gubitz AK, Massenet S, Dreyfuss G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol 2002;14:305-312. (Pubitemid 34626968)
12. Yong J, Wan L, Dreyfuss G. Why do cells need an assembly machine for RNA-protein complexes? Trends Cell Biol 2004;14:226-232. (Pubitemid 38591326)
13. Monani UR. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 2005;48:885-896. (Pubitemid 41814694)
14. Zhang HL, Pan F, Hong D, Shenoy SM, Singer RH, Bassell GJ. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 2003;23:6627-6637. (Pubitemid 36909889)
15. Rossoll W, Jablonka S, Andreassi C, et al. SMN, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol 2003;163: 801-812. (Pubitemid 37517887)
16. Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy. Hum Mutat 2000;15:228-237. (Pubitemid 30132157)
17. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997;61:40-50. (Pubitemid 27323322)
18. McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997;60:1411-1422. (Pubitemid 27258073)
19. Wirth B, Herz M, Wetter A, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999;64:1340-1356. (Pubitemid 30468752)
20. Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4:20-26. (Pubitemid 44698460)
21. Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet A 2004;130:207-310.
22. Hsieh-Li HM, Chang JG, Jong YJ, et al. A mouse model for spinal muscular atrophy. Nat Genet 2000;26:66-70. (Pubitemid 30041423)
23. Monani UR, Coovert DD, Burghes AH. Animal models of spinal muscular atrophy. Hum Mol Genet 2000;9:2451-2457.
24. Hoffman Y, Lorson CL, Stamm S, Androphy EJ, Wirth B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci USA 2000;97:9618-9623. (Pubitemid 30650825)
25. Oprea GE, Krober S, McWhorter ML, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008; 320:524-527. (Pubitemid 351590664)
26. Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000; 9:259-265.
27. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999;96:6307-6311. (Pubitemid 29256661)
28. Cartegni L, Kraniner AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002;30:377-384.
29. Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003;34:460-463. (Pubitemid 36935342)
30. Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH. Differential SMN2 expression associated with SMA severity. Nat Genet 1998;20:230-231. (Pubitemid 28507664)
31. Prior TW, Krainer AR, Hua Y, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 2009;85:408-413.
32. Alias L, Bernal S, Fuentes-Prior P, et al. Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 2009; 125:29-39.
33. Parsons DW, McAndrew PE, Iannaccone ST, et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect and modification of spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 1998;63:1712-1723. (Pubitemid 30415734)
34. Hendrickson BC, Donohoe C, Akmaev VR, et al. Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet 2009;46:641-644.
35. Ogino S, Wilson RB. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet 2002;111:477-500. (Pubitemid 36075081)
36. Ogino S, Wilson RB, Gold B. New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Eur J Hum Genet 2004;12:1015-1023. (Pubitemid 39600129)
37. Eggermann T. A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches. Neuromusc dis 2008;18: 146-149.
38. Wirth B, Schmidt T, Hahnen E, et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997;61:1102-1111. (Pubitemid 27492318)
39. Prior TW. Carrier screening for spinal muscular atrophy. Genet Med 2008; 10:840-842.
40. ACOG Committee Opinion. Spinal muscular atrophy. Obstet Gynecol 2009; 113:1194-1196.
41. Smith M, Calabro V, Chong B, et al. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet 2007;15:759-766. (Pubitemid 46965409)
42. Prior TW. Perspectives and diagnostic considerations in spinal muscular atrophy. Genet Med 2010;12:145-152.
43. van der Steege G, Grootscholten P, van der Vlies, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995;345:985-986.
44. Huang C-H, Chang YY, Chen CH. Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification. Genet Med 2007;9:241-248. (Pubitemid 46626094)
45. Anhuf D, Eggermann T, Rudnik-Schoneborn S, Zerres K. Determination of SMN1 and SMN2 copy number using Taqman technology. Hum Mutat 2003;22:74-78. (Pubitemid 36807775)
46. Cheng S, Fockler C, Barnes WM, Higuchi R. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 1994;91:5695-5699. (Pubitemid 24174395)